parecoxib has been researched along with Bone Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gaivão, I; Lemos, S; Ludovico, P; Martins, G; Oliveira, P; Palmeira, C; Peixoto, F; Pinto-Leite, R; Sampaio-Marques, B | 1 |
Chen, J; Cong, X; Zhan, X; Zheng, W; Zhou, Z | 1 |
Bhagat, S; Fullerton, SL; Kenner, DJ | 1 |
3 other study(ies) available for parecoxib and Bone Neoplasms
Article | Year |
---|---|
Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Osteosarcoma; Tumor Cells, Cultured | 2020 |
Effects of Parecoxib on Pain Threshold and Inflammatory Factors IL-1β, IL-6 and TNF-
Topics: Animals; Bone Neoplasms; Cancer Pain; Cyclooxygenase 2 Inhibitors; Down-Regulation; Female; Hyperalgesia; Inflammation; Interleukin-1beta; Interleukin-6; Isoxazoles; Pain Threshold; Random Allocation; Rats; Rats, Sprague-Dawley; Spinal Cord; Tumor Necrosis Factor-alpha | 2019 |
Daily subcutaneous parecoxib injection for cancer pain: an open label pilot study.
Topics: Analgesics, Opioid; Analysis of Variance; Bone Neoplasms; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; Hospital Units; Humans; Injections, Subcutaneous; Isoxazoles; Male; Neoplasm Metastasis; Pain Management; Pain Measurement; Palliative Care; Pilot Projects; Treatment Outcome; Victoria | 2015 |